Notice of Zealand's interim report for H1 2016 and related conference call

• On the day of release, Thursday 25 August 2016 at 2.00pm CET, Zealand's senior management will host a conference call. The conference call can be accessed via live audio webcast from Zealand's website.

Copenhagen, 17 August 2016 - Zealand Pharma (Zealand) confirms the release of its interim report for H1 2016 on Thursday 25 August 2016 in accordance with the company's financial calendar. The release can be expected in the morning.   

Conference call on Thursday, 25 August 2016 at 2.00pm CET

On the day of release, Zealand's senior management will host a conference call at 2.00pm CET to present the interim report for H1 2016. Participating in the call will be Britt Meelby Jensen, President and Chief Executive Officer, Mats Blom, SVP and Chief Financial Officer, Adam Steensberg, SVP and Chief Medical and Development Officer and Hanne Leth Hillman, SVP and Head of IR and Communications. The presentation will be followed by a Q&A session.

The conference call will be conducted in English and the dial-in numbers are:

DK standard access     +45 32 71 16 60

UK and international    +44 (0) 20 7136 6283

US (free dial-in)            +1 646 254 3388

Kindly inform the operator of the following passcode: 7959175

A live audio webcast of the call including an accompanying slide presentation will be available via the following link, http://edge.media-server.com/m/p/m4rcono7, accessible also from the company's website (www.zealandpharma.com). Participants are advised to register for the webcast approximately 10 minutes before the start.

A replay of the event will be made available from the Investor section of Zealand's website following the call.

●●●●●

For further information, please contact:

Hanne Leth Hillman, Senior Vice President, Investor Relations and Communications

Tel: +45 50 60 36 89, email: hlh@zealandpharma.com

Vedhæftede filer:

06-16_0817 - Investor News - Notice of interim report for H1 2016 and TC- ENG_Final.pdf